CIK 0000944809
- Accelerated filer
OPKO HEALTH, INC.
Sign in to watch- Ticker
- OPK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 752402409
- Phone
- +1 305-575-4181
- Business address
- 4400 BISCAYNE BLVD., MIAMI, FL, 33137
- Former names
- EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,577
- in 1 filing
Net −$24,577. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-07 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +9,100 | $1.85 | $17K | 200,474,251 |
| 2023-08-07 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +160,243 | $1.85 | $296K | 200,634,494 |
| 2023-08-07 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +21,432 | $1.86 | $40K | 200,655,926 |
| 2023-08-07 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +25,768 | $1.86 | $48K | 200,681,694 |
| 2023-06-22 | Yu Alice Lin-Tsing Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-06-22 | PFENNIGER RICHARD C JR Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2023-06-22 | PAGANELLI JOHN A Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-06-22 | MEDEL ROGER MD Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-06-22 | Lachman Prem A Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-06-22 | KRASNO RICHARD M Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-06-22 | Borisy Alexis Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-05-18 | FROST PHILLIP MD ET AL CEO & Chairman | Grant or award · Stock Option (Right to Buy) | +800,000 | 800,000 | ||
| 2023-05-18 | HSIAO JANE PH D Vice Chairman & CTO | Grant or award · Stock Option (Right to Buy) | +800,000 | 800,000 | ||
| 2023-05-18 | Zerhouni Elias A. Vice Chairman and President | Grant or award · Stock Option (Right to Buy) | +800,000 | 800,000 | ||
| 2023-05-18 | Rubin Steven D Executive VP-Administration | Grant or award · Stock Option (Right to Buy) | +700,000 | 700,000 | ||
| 2023-05-18 | Logal Adam Sr. Vice President, CFO | Grant or award · Stock Option (Right to Buy) | +700,000 | 700,000 | ||
| 2023-05-18 | Nabel Gary J. Chief Innovation Officer | Grant or award · Stock Option (Right to Buy) | +700,000 | 700,000 | ||
| 2023-05-05 | Nabel Gary J. Chief Innovation Officer | Purchase | +19,285 | $1.78 | $34K | 94,756 |
| 2023-05-05 | Nabel Gary J. Chief Innovation Officer | Purchase | +3,185 | $1.79 | $6K | 97,941 |
| 2023-05-05 | Nabel Gary J. Chief Innovation Officer | Purchase | +27,777 | $1.80 | $50K | 125,718 |
Page 10 of 33 · 653 trades